Sarepta Therapeutics, Inc. (SRPT) SEC filings
SRPT SEC filings moved a median of -0.55% by the close. SRPT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SRPT overview →
50 measured SRPT SEC filing events.
Where these SRPT SEC filings landedvs 50 measured SRPT SEC filing reactions
| Middle 50% of SRPT SEC filing reactions | -2.28% to +1.96% |
|---|---|
| Median reaction (to close) | -0.55% |
| Measured reactions | 50 |
Point-in-time · zero look-ahead
Half of the 50 SRPT SEC filing events with a measured close landed between -2.28% and +1.96%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Sarepta Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +1.23% | -1.97% | |
| Form 13F-HR Sarepta Therapeutics, For: Jun 30 | SEC filing · Form 13F-HR | -1.65% | -0.66% | |
| Form 10-Q Sarepta Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.44% | +0.72% | |
| Form 8-K Sarepta Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +1.44% | +0.72% | |
| Form S-8 Sarepta Therapeutics, | SEC filing · Form S-8 | +0.00% | +0.68% | |
| Form 8-K Sarepta Therapeutics, For: Jul 23 | SEC filing · Form 8-K | +1.94% | -2.04% | |
| Form 8-K Sarepta Therapeutics, For: Jun 04 | SEC filing · Form 8-K | -0.42% | -5.06% | |
| Form S-8 Sarepta Therapeutics, | SEC filing · Form S-8 | -0.42% | -5.06% | |
| Form 13F-HR Sarepta Therapeutics, For: Mar 31 | SEC filing · Form 13F-HR | -0.21% | -3.31% | |
| Form 10-Q Sarepta Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.61% | -5.84% | |
| Form 8-K Sarepta Therapeutics, For: May 06 | SEC filing · Form 8-K | +0.61% | -5.84% | |
| Form ARS Sarepta Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.54% | +3.04% | |
| Form DEF 14A Sarepta Therapeutics, For: Jun 04 | SEC filing · Form DEF | +0.54% | +3.04% | |
| Form DEFA14A Sarepta Therapeutics, | SEC filing · Form DEFA14A | +0.54% | +3.04% | |
| Form 10-K Sarepta Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.39% | +0.74% | |
| Form 8-K Sarepta Therapeutics, For: Feb 25 | SEC filing · Form 8-K | -2.85% | -1.97% | |
| Form 13F-HR Sarepta Therapeutics, For: Dec 31 | SEC filing · Form 13F-HR | +1.25% | +1.31% | |
| Form 8-K Sarepta Therapeutics, For: Jan 12 | SEC filing · Form 8-K | +1.47% | +0.24% | |
| Form 8-K Sarepta Therapeutics, For: Dec 18 | SEC filing · Form 8-K | +2.88% | +1.73% | |
| Form 8-K Sarepta Therapeutics, For: Dec 10 | SEC filing · Form 8-K | +2.71% | +3.28% | |
| Form 8-K Sarepta Therapeutics, For: Dec 07 | SEC filing · Form 8-K | -0.39% | -2.97% | |
| Form 10-Q Sarepta Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.17% | -0.79% | |
| Form 8-K Sarepta Therapeutics, For: Nov 03 | SEC filing · Form 8-K | +4.63% | +6.30% | |
| Form 8-K Sarepta Therapeutics, For: Aug 28 | SEC filing · Form 8-K | +1.88% | +0.61% | |
| Form 8-K Sarepta Therapeutics, For: Aug 18 | SEC filing · Form 8-K | -0.65% | +3.83% | |
| Form 8-K Sarepta Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +0.50% | +0.69% | |
| Form 10-Q Sarepta Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.25% | -1.59% | |
| Form S-8 Sarepta Therapeutics, | SEC filing · Form S-8 | +2.25% | -1.59% | |
| Form 8-K Sarepta Therapeutics, For: Jul 21 | SEC filing · Form 8-K | +1.24% | +3.98% | |
| Form 8-K Sarepta Therapeutics, For: Jul 14 | SEC filing · Form 8-K | -0.21% | -2.36% | |
| Form 8-K Sarepta Therapeutics, For: Jun 05 | SEC filing · Form 8-K | -2.76% | -9.28% | |
| Form 10-Q Sarepta Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.57% | -8.20% | |
| Form ARS Sarepta Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.86% | -2.01% | |
| Form DEF 14A Sarepta Therapeutics, For: Jun 05 | SEC filing · Form DEF | -1.86% | -2.01% | |
| Form DEFA14A Sarepta Therapeutics, | SEC filing · Form DEFA14A | -1.86% | -2.01% | |
| Form S-3ASR Sarepta Therapeutics, | SEC filing · Form S-3ASR | -0.27% | +2.60% | |
| Form 10-K Sarepta Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.12% | -5.18% | |
| Form 8-K Sarepta Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +6.09% | +2.04% | |
| Form 8-K Sarepta Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +1.24% | -1.72% | |
| Form 8-K Sarepta Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -0.16% | -5.17% | |
| Form 8-K Sarepta Therapeutics, For: Nov 24 | SEC filing · Form 8-K | +3.37% | +12.53% | |
| Form 10-Q Sarepta Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.06% | -9.05% | |
| Form 8-K Sarepta Therapeutics, For: Sep 12 | SEC filing · Form 8-K | +0.18% | -1.14% | |
| Form 10-Q Sarepta Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.30% | +1.41% | |
| Form S-8 Sarepta Therapeutics, | SEC filing · Form S-8 | +0.30% | +1.41% | |
| Form 8-K Sarepta Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +0.57% | -0.44% | |
| Form 10-Q Sarepta Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.69% | |
| Form ARS Sarepta Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.08% | +3.57% | |
| Form DEF 14A Sarepta Therapeutics, For: Jun 06 | SEC filing · Form DEF | -0.08% | +3.57% | |
| Form DEFA14A Sarepta Therapeutics, | SEC filing · Form DEFA14A | -0.08% | +3.57% |
Keep exploring
More SRPT: earnings → · analyst actions → · SRPT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NuVasive, Inc. (NUVA) | 1,226 | +0.03% | 51% |
| DENTSPLY SIRONA Inc. (XRAY) | 1,226 | +0.05% | 52% |
| Orthofix Medical Inc. (OFIX) | 1,217 | +0.06% | 51% |
| IMMUNOMEDICS (IMMU) | 1,213 | -0.08% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.